“…We then filtered only for clear-cut protein changing SNPs (missense mutations predicted deleterious by SIFT, nonsense mutations, splice site mutations, start codon mutations, and within-exon deletions and duplications), as such changes are potentially more amenable to function tests of pathogenicity; reducing from 18,106 SNPs prior to SIFT and pathogenicity analysis to 3,596 afterward. We then further filtered only for SNPs within ion channel genes, as members of this group of genes have already been implicated in Mendelian pain disorders, and testing techniques for ion channel function are well established; resulting in 28 SNPs ( Stevens and Stephens, 2018 ). For all SNPs, especially those whose rare allele frequency is < 5%, geographical and ethnic differences must be considered; rs140124801 has a rare allele frequency in EVS of 0.0051 (cohort size 6500), in gNOMAD Europeans = 0.0072 (cohort size 18,878), 1000 Genomes = 0.0048 (cohort size 2,504), and our population were Caucasian and predominantly born in the United Kingdom.…”